BioNano Genomics's total assets for Q2 2026 were $47.59M, a decrease of -26.56% from the previous quarter. MX:BNGO total liabilities were $15.98M for the fiscal quarter, a -41.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.